A biomarker of exposure to environmental tobacco smoke (ETS) and Ernst Wynder's opinion about ETS and lung cancer

Preventive Medicine

Volumn 43, Issue 4, 2006, Pages 256-260

  Hecht, Stephen S ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

4 (Methylnitrosamino) 1 (3 pyridyl) 1 butanol (NNAL) and its glucuronides (NNAL Glucs); 4 (Methylnitrosamino) 1 (3 pyridyl) 1 butanone (NNK); Biomarkers; Environmental tobacco smoke; Secondhand tobacco smoke

Indexed keywords

4 (METHYLNITROSAMINO) 1 (3 PYRIDYL) 1 BUTANOL; 4 (METHYLNITROSAMINO) 1 (3 PYRIDYL) 1 BUTANONE; BIOLOGICAL MARKER; CARCINOGEN; GLUCURONIDE; TOBACCO SMOKE;

ARTICLE; ENVIRONMENTAL EXPOSURE; HUMAN; LUNG CANCER; PASSIVE SMOKING; PRIORITY JOURNAL; URINE;

AIR POLLUTION, INDOOR; BIOLOGICAL MARKERS; GLUCURONATES; HISTORY, 20TH CENTURY; HUMANS; LUNG NEOPLASMS; NITROSAMINES; PUBLIC HEALTH; TOBACCO SMOKE POLLUTION;

EID: 33749533967     PISSN: 00917435     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ypmed.2006.07.020     Document Type: Article

References (23)

1. Anderson K.E., Carmella S.G., Ye M., Bliss R., Le C., Murphy L., and Hecht S.S. Metabolites of a tobacco-specific lung carcinogen in the urine of nonsmoking women exposed to environmental tobacco smoke in their homes. J. Natl. Cancer Inst. 93 (2001) 378-381
2. Anderson K.E., Kliris J., Murphy L., Carmella S.G., Hen S., Link C., Bliss R.L., Murphy S.E., and Hecht S.S. Metabolites of a tobacco-specific lung carcinogen in nonsmoking casino patrons. Cancer Epidemiol. Biomarkers Prev. 12 (2003) 1544-1546
3. 6-methylguanine formation in Clara cells and induction of pulmonary neoplasia in the rat by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. Cancer Res. 50 (1990) 3772-3780
4. Carmella S.G., Akerkar S., and Hecht S.S. Metabolites of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in smokers' urine. Cancer Res. 53 (1993) 721-724
5. Environmental Protection Agency. Respiratory Health Effects of Passive Smoking: Lung Cancer and Other Disorders (1992), Office of Health and Environmental Assessment and Office of Research and Development, Washington, DC
6. Fields N., and Chapman S. Chasing Ernst L Wynder: 40 years of Philip Morris' efforts to influence a leading scientist. J. Epidemiol. Community Health 57 (2003) 571-578
7. Hecht S.S. Environmental tobacco smoke and lung cancer: the emerging role of carcinogen biomarkers and molecular epidemiology (Editorial). J. Natl. Cancer Inst. 86 (1994) 1369-1370
8. Hecht S.S. Biochemistry, biology, and carcinogenicity of tobacco-specific N-nitrosamines. Chem. Res. Toxicol. 11 (1998) 559-603
9. Hecht S.S. Carcinogen derived biomarkers: applications in studies of human exposure to secondhand tobacco smoke. Tob. Control 13 Suppl. 1 (2003) i48-i56
10. Hecht S.S., and Hoffmann D. Tobacco-specific nitrosamines, an important group of carcinogens in tobacco and tobacco smoke. Carcinogenesis 9 (1988) 875-884
11. Hecht S.S., Young R., and Chen C.B. Metabolism in the F344 rat of 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone, a tobacco specific carcinogen. Cancer Res. 40 (1980) 4144-4150
12. Hecht S.S., Carmella S.G., Murphy S.E., Akerkar S., Brunnemann K.D., and Hoffmann D. A tobacco-specific lung carcinogen in the urine of men exposed to cigarette smoke. N. Engl. J. Med. 329 (1993) 1543-1546
13. Hecht S.S., Trushin N., Reid-Quinn C.A., Burak E.S., Jones A.B., Southers J.L., Gombar C.T., Carmella S.G., Anderson L.M., and Rice J.M. Metabolism of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in the Patas monkey: pharmacokinetics and characterization of glucuronide metabolites. Carcinogenesis 14 (1993) 229-236
14. Hecht S.S., Ye M., Carmella S.G., Fredrickson A., Adgate J.L., Greaves I.A., and Church T.R. Metabolites of a tobacco-specific lung carcinogen in the urine of elementary school-aged children. Cancer Epidemiol. Biomarkers Prev. 10 (2001) 1109-1116
15. Hecht S.S., Carmella S.G., Le K., Murphy S.E., Boettcher A.J., Le C., Koopmeiners J., and Hennrikus D.J. Metabolites of a tobacco-specific carcinogen in the urine of infants exposed to environmental tobacco smoke. Cancer Epidemiol. Biomarkers Prev. 15 (2006) 988-992
16. International Agency for Research on Cancer. Tobacco smoke and involuntary smoking. IARC monographs on the evaluation of carcinogenic risks to humans vol. 83 (2004), IARC, Lyon, FR 1191-1413
17. International Agency for Research on Cancer, in press. Smokeless tobacco and tobacco-specific nitrosamines. IARC monographs on the evaluation of carcinogenic risks to humans. IARC, Lyon, FR, vol. 89.
18. Kabat G.C., Stellman S.D., and Wynder E.L. Relation between exposure to environmental tobacco smoke and lung cancer in lifetime nonsmokers. Am. J. Epidemiol. 142 (1995) 141-148
19. Morse M.A., Eklind K.I., Toussaint M., Amin S.G., and Chung F.L. Characterization of a glucuronide metabolite of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and its dose-dependent excretion in the urine of mice and rats. Carcinogenesis 11 (1990) 1819-1823
20. Parsons W.D., Carmella S.G., Akerkar S., Bonilla L.E., and Hecht S.S. A metabolite of the tobacco-specific lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in the urine of hospital workers exposed to environmental tobacco smoke. Cancer Epidemiol. Biomarkers Prev. 7 (1998) 257-260
21. Stepanov I., Hecht S.S., Duca G., and Mardari I. Uptake of the tobacco-specific lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) by Moldovan children. Cancer Epidemiol. Biomarkers Prev. 15 (2006) 7-11
22. Tulunay O., Hecht S.S., Carmella S.G., Zhang Y., Lemmonds C., Murphy S.E., and Hatsukami D.K. Urinary metabolites of a tobacco-specific lung carcinogen in nonsmoking hospitality workers. Cancer Epidemiol. Biomarkers Prev. 14 (2005) 1283-1286
23. Wynder E.L., and Graham E.A. Tobacco smoking as a possible etiologic factor in bronchiogenic carcinoma. A study of six hundred and eighty-four proved cases. J. Am. Med. Assoc. 143 (1950) 329-336